Dr. Joseph James Laconti, MD, PhD

Dr. Laconti practices at Miami Sunset Surgery Center,LLC in Miami, Florida.

Dr. Laconti's NPI, 1831465954, was assigned on March 23, 2012. Dr. Laconti graduated from Georgetown University School Of Medicine in 2012. Dr. Laconti holds Florida license ME127921.

Dr. Laconti's primary practice is Miami Sunset Surgery Center,LLC, at 7190 Sw 87th Ave, Miami, FL 33173 in Miami-Dade County. The practice phone is (305) 596-2228.

Dr. Laconti's primary practice is Miami Sunset Surgery Center,LLC in Miami, Florida. Dr. Laconti is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Universal Therapy Center Inc. Dmand AI also links Dr. Laconti to 1 more hospital, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laconti practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Laconti's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Laconti is board certified in internal medicine by the American Board of Internal Medicine. Dr. Laconti is licensed in Florida.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Laconti treats.

CMS data shows 83,035 Medicare services from Dr. Laconti across 29 procedure codes in 2024, for 448 Medicare patients. Medicare paid $845,836 for them. Every service was in an office.

CMS counts 448 Medicare patients who saw Dr. Laconti in 2024. The largest group is 65 to 74, with 201 patients. 75% of them have arthritis, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Laconti's median patient age at 67, with 79% women.

In 2024, Dr. Laconti wrote 5,137 Medicare Part D claims for 805 patients. 92% of them were for generic drugs. CMS names the drug for 4,947 of them, across 45 drugs with 11 or more claims each, at $2,378,776 in total drug cost. In 2023, CMS named 5,346 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Laconti for performance year 2024, reported as part of a group. Dr. Laconti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Laconti as offering telehealth.

Dmand AI links 6 papers to Dr. Laconti, published from 2011 to 2024. The most frequent topics are Pancreatic Neoplasms and Proto-Oncogene Proteins p21(ras). Dr. Laconti's most frequent co-authors are Rohit Aggarwal, MD, Dana P. Ascherman, MD and Jamie S. Barkin, MD.

CMS Open Payments shows 1,397 general payments to Dr. Laconti from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Abbvie Inc. paid the most, $242,559.

Dmand AI lists 1 award for Dr. Laconti, most recently Ambulatory Care Award in 2015.

Dr. Laconti graduated from Georgetown University School Of Medicine in 2012. Dr. Laconti is a member of ACP, ACR and AMA.

Dr. Laconti is in network with 13 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.